News & Events

  • We are proud to announce that BioXtreme is awarded a R&D grant from the Israel Innovation Authority

    01/08/2020

    Click here to read more…

  • BioXtreme and Heliomare rehabilitation centre will conduct a joint clinical trial research project on deXtreme™ in Heliomare facility in the Netherlands

    01/03/2020

    Click here to read more…

  • BioXtreme is proud to announce that our product, deXtreme™ is FDA registered!

    17/01/2020

    Registration took place at 17/2/2020. BioXtreme’s FDA owner/operator number is 10062549

  • BioXtreme will exhibit in 11th World Congress for Neurorehabilitation

    07-10/10/2020, Lyon France
    Please join us at booth #47
    https://www.wcnr-congress.org
    https://www.bio-xtreme.com/wp-content/uploads/2020/01/WCNR2020_Banner.jpeg

  • BioXtreme will showcase deXteme™ 3.0 in the upcoming European Neuro Convention

    09/11-10/03/2021, Birmingham UK
    Come join us in booth #316
    http://www.neuroconvention.com
    https://www.bio-xtreme.com/wp-content/uploads/2020/01/event.png